Literature DB >> 26343181

Effects of Race and Sex on Features of Eosinophilic Esophagitis.

Fouad J Moawad1, Evan S Dellon2, Sami R Achem3, Tony Ljuldjuraj4, Daniel J Green2, Corinne L Maydonovitch5, Diana R Brizuela3, Sandeep K Gupta4, Mirna Chehade6.   

Abstract

BACKGROUND & AIMS: Clinical and endoscopic features of eosinophilic esophagitis (EoE) differ between children and adults and among racial backgrounds. We investigated whether there were any associations between race or sex and clinical presentation, endoscopic features, and histologic findings from patients with EoE of various racial backgrounds.
METHODS: We performed a retrospective, multicenter, cross-sectional analysis of 793 patients with EoE (476 adults and 317 children; mean age, 26 years; range, 0.1-84 years; 72% male) from clinical registries at 5 tertiary care centers in the United States. EoE was defined per consensus guidelines. Data with predetermined variables were extracted from clinical registries at each participating institution.
RESULTS: Of the study cohort, 660 patients were white (83%), 77 were African American (10%), and 56 were of other races (7%). A significantly larger proportion of white persons than African Americans or other races had dysphagia (74%, 56%, and 53%, respectively; P < .001), food impaction (35%, 13%, and 13%, respectively; P < .001), and features of EoE that included rings (46%, 25%, and 18%, respectively; P < .001) or furrows (70%, 58%, and 55%, respectively; P = .012). Males and females had similar clinical presentations, histories of atopy, findings from endoscopy, and histologic characteristics. A higher proportion of males than females had strictures (17% vs 11%; P = .038).
CONCLUSIONS: Race, and to a smaller degree sex, are associated with features of EoE. African Americans have different clinical symptoms and fewer endoscopic features of EoE than white persons. EoE should be considered in African Americans even without typical findings.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergy; Eosinophilic Esophagitis; Epidemiology; Food; Race

Mesh:

Year:  2015        PMID: 26343181     DOI: 10.1016/j.cgh.2015.08.034

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  18 in total

1.  Long-Term Treatment of Eosinophilic Esophagitis With Swallowed Topical Corticosteroids: Development and Evaluation of a Therapeutic Concept.

Authors:  Thomas Greuter; Christian Bussmann; Ekaterina Safroneeva; Alain M Schoepfer; Luc Biedermann; Stephan R Vavricka; Alex Straumann
Journal:  Am J Gastroenterol       Date:  2017-07-18       Impact factor: 10.864

2.  The Prevalence of Biopsy-Proven Eosinophilic Esophagitis in Hispanics Undergoing Endoscopy Is Infrequent Compared to Caucasians: A Cross-Sectional Study.

Authors:  Christine Yu; Dubin Sterling; Ihsan Albayati; Sarah Al-Obaidi; Sharareh Moraveji; Marco A Bustamante; Alireza Torabi; Nawar Hakim; Alan Naim; Anand Dutta; Pratik S Naik; Richard W McCallum
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

3.  17β-Estradiol protects the esophageal epithelium from IL-13-induced barrier dysfunction and remodeling.

Authors:  Justin C Wheeler; Simone Vanoni; Chang Zeng; Lisa Waggoner; Yanfen Yang; David Wu; Jazib Uddin; Rebekah Karns; Leah Kottyan; Vincent Mukkada; Marc E Rothenberg; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2018-12-20       Impact factor: 10.793

4.  Internalized Stigma in Patients with Eosinophilic Gastrointestinal Disorders.

Authors:  L Guadagnoli; T H Taft
Journal:  J Clin Psychol Med Settings       Date:  2020-03

5.  Low Prevalence of Biopsy-Proven Eosinophilic Esophagitis in Patients with Esophageal Food Impaction in Mexican Population.

Authors:  Diego García-Compeán; José A González-González; José J Duran-Castro; Gilberto Herrera-Quiñones; Omar D Borjas-Almaguer; Héctor J Maldonado-Garza
Journal:  Dig Dis Sci       Date:  2018-03-29       Impact factor: 3.199

Review 6.  Eosinophilic Esophagitis Clinical Manifestations and Differential Diagnosis.

Authors:  Diana Muñoz-Mendoza; Adrián Chapa-Rodríguez; Sami L Bahna
Journal:  Clin Rev Allergy Immunol       Date:  2018-08       Impact factor: 8.667

7.  New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting.

Authors:  Jonathan M Spergel; Seema S Aceves; Kara Kliewer; Nirmala Gonsalves; Mirna Chehade; Joshua B Wechsler; Marion Groetch; Joshua Friedlander; Evan S Dellon; Wendy Book; Ikuo Hirano; Amanda B Muir; Antonella Cianferoni; Lisa Spencer; Chris A Liacouras; Edaire Cheng; Leah Kottyan; Ting Wen; Thomas Platts-Mills; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2018-05-24       Impact factor: 10.793

8.  Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research.

Authors:  Mirna Chehade; Stacie M Jones; Robbie D Pesek; A Wesley Burks; Brian P Vickery; Robert A Wood; Donald Y M Leung; Glenn T Furuta; David M Fleischer; Alice K Henning; Peter Dawson; Robert W Lindblad; Scott H Sicherer; J Pablo Abonia; Joseph D Sherrill; Hugh A Sampson; Marc E Rothenberg
Journal:  J Allergy Clin Immunol Pract       Date:  2018-08-01

Review 9.  Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?

Authors:  Emily Ko; Mirna Chehade
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

10.  Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.

Authors:  Dustin Albert; Theresa A Heifert; Steve B Min; Corinne L Maydonovitch; Thomas P Baker; Yen-Ju Chen; Fouad J Moawad
Journal:  Dig Dis Sci       Date:  2016-04-19       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.